| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Diagnostics | $441.50M | $387.40M | $359.50M | $427.50M | $482.80M | $450.40M | $419.20M | $458.70M |
| Biopharma Laboratory Services | — | — | — | $106.90M | $123.30M | $132.20M | $136.10M | $120.70M |
| Corporate Segment | -$180.30M | -$172.50M | -$189.10M | -$132.40M | -$139.20M | -$109.90M | -$100.70M | -$116.60M |
| Total | $294.80M | $254.10M | $216.50M | $326.00M | $394.50M | $396.60M | $267.60M | $380.80M |